Eterna Therapeutics Inc
ERNA1.511USD
-0.049-3.13%
取引時間 （ET）15分遅れの株価
78.95M時価総額
損失額直近12ヶ月PER
詳細情報 Eterna Therapeutics Inc 企業名
Eterna Therapeutics Inc. is a life science company committed to realizing the potential of messenger ribonucleic acid (RNA) (mRNA) cell engineering to provide patients with transformational new medicines. The Company has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.
企業情報
企業コードERNA
会社名Ernexa Therapeutics Inc
上場日Aug 29, 1991
最高経営責任者「CEO」Mr. Sanjeev Luther
従業員数6
証券種類Ordinary Share
決算期末Aug 29
本社所在地1035 Cambridge Street
都市CAMBRIDGE
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号02141
電話番号16177986700
ウェブサイトhttps://www.ernexatx.com/
企業コードERNA
上場日Aug 29, 1991
最高経営責任者「CEO」Mr. Sanjeev Luther
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. James Bristol
Dr. James Bristol
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sanjeev Luther
Mr. Sanjeev Luther
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Sandra Gurrola
Ms. Sandra Gurrola
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Mr. Peter Cicala
Mr. Peter Cicala
Independent Director
Independent Director
--
--
Dr. Elena Ratner
Dr. Elena Ratner
Independent Director
Independent Director
--
--
Mr. William Wexler
Mr. William Wexler
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. James Bristol
Dr. James Bristol
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sanjeev Luther
Mr. Sanjeev Luther
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Sandra Gurrola
Ms. Sandra Gurrola
Senior Vice President - Finance
Senior Vice President - Finance
--
--
Mr. Peter Cicala
Mr. Peter Cicala
Independent Director
Independent Director
--
--
Dr. Elena Ratner
Dr. Elena Ratner
Independent Director
Independent Director
--
--
Mr. William Wexler
Mr. William Wexler
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Mon, Feb 24
通貨: USD更新時刻: Mon, Feb 24
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Subscription revenue
4.88M
84.17%
Other revenue
492.00K
8.48%
Hardware revenue
426.00K
7.34%
地域別USD
会社名
収益
比率
United States
5.48M
94.48%
Canada
320.00K
5.52%
事業別
地域別
事業別USD
会社名
収益
比率
Subscription revenue
4.88M
84.17%
Other revenue
492.00K
8.48%
Hardware revenue
426.00K
7.34%
株主
更新時刻: Thu, Jul 31
更新時刻: Thu, Jul 31
株主統計
種類
株主統計
株主統計
比率
Cherington (Charles)
37.73%
Freebird Partners LP
5.63%
Halpern (John D)
5.30%
Denny George P Iii
4.52%
Regolith Capital Investments LP
3.03%
Other
43.79%
株主統計
株主統計
比率
Cherington (Charles)
37.73%
Freebird Partners LP
5.63%
Halpern (John D)
5.30%
Denny George P Iii
4.52%
Regolith Capital Investments LP
3.03%
Other
43.79%
種類
株主統計
比率
Individual Investor
48.37%
Corporation
12.51%
Investment Advisor/Hedge Fund
0.52%
Hedge Fund
0.27%
Investment Advisor
0.24%
Research Firm
0.16%
Venture Capital
0.04%
Other
37.90%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
52
4.57M
62.09%
+1.56M
2025Q1
56
2.92M
80.53%
+838.33K
2024Q4
54
33.02M
64.27%
+30.12M
2024Q3
67
2.84M
52.46%
-257.40K
2024Q2
83
2.52M
46.53%
-624.19K
2024Q1
121
2.54M
46.88%
-584.16K
2023Q4
126
2.36M
43.79%
-543.57K
2023Q3
142
2.77M
52.76%
-391.46K
2023Q2
146
2.77M
53.56%
-376.86K
2023Q1
150
2.98M
67.03%
+101.08K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Cherington (Charles)
2.78M
37.73%
+1.42M
+104.20%
Jun 09, 2025
Freebird Partners LP
414.10K
5.63%
--
--
Apr 14, 2025
Halpern (John D)
390.45K
5.3%
--
--
Apr 14, 2025
Denny George P Iii
332.71K
4.52%
+3.36K
+1.02%
Apr 14, 2025
Regolith Capital Investments LP
222.88K
3.03%
--
--
Apr 14, 2025
IAF, LLC
217.03K
2.95%
--
--
Apr 14, 2025
Purchase Capital LLC
66.67K
0.91%
+66.67K
--
Dec 31, 2024
Singer (Nicholas Jason)
54.00K
0.73%
+54.00K
--
Dec 31, 2024
Geode Capital Management, L.L.C.
19.54K
0.27%
+2.39K
+13.93%
Mar 31, 2025
Corient Private Wealth LLC
17.52K
0.24%
--
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
日付
種類
比率
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Oct 12, 2022
Merger
20<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
Mar 24, 2021
Merger
2<1
